Related Experiment Video
Updated: May 31, 2025

A Human Glioblastoma Organotypic Slice Culture Model for Study of Tumor Cell Migration and Patient-specific Effects of Anti-Invasive Drugs
Published on: July 20, 2017
Decoding the Role of Kinesin Superfamily Proteins in Glioma Progression
Mohamed J Saadh1, Zahraa Sabah Ghnim2, Morug Salih Mahdi3
1Faculty of Pharmacy, Middle East University, Amman, 11831, Jordan. mohamedjsaadh@gmail.com.
Abstract:
Glioma is a highly aggressive and invasive brain tumor with limited treatment options, highlighting the need for novel therapeutic approaches. Kinesin superfamily proteins (KIFs) are a diverse group of motor proteins that play essential roles in cellular processes such as mitosis, intracellular transport, and signal transduction, all of which are crucial for tumorigenesis. This review focuses on the multifaceted role of KIFs in glioma, examining their clinical relevance, contribution to tumor progression, and potential as therapeutic targets. We discuss how KIFs influence key aspects of glioma biology, including cell proliferation, invasion, migration, and metastasis. Furthermore, we explore the regulation of the cell cycle and critical signaling pathways associated with glioma, such as PI3K-Akt, Wnt/β-catenin, and Hedgehog signaling by KIFs. The review also addresses the emerging interplay between KIFs and non-coding RNAs, including circular RNAs (circRNAs) and microRNAs (miRNAs), in glioma progression. Finally, we examine current therapeutic strategies targeting KIFs, including immunotherapy, chemotherapy, and small-molecule inhibitors, and their potential to improve treatment outcomes for glioma patients. By synthesizing these insights, this review underscores the significance of KIFs in glioma pathogenesis and their promise as novel therapeutic targets in the fight against glioma.
Insights
Kinesin superfamily proteins (KIFs) are crucial for glioma development and progression. Targeting KIFs offers a promising new strategy for treating aggressive brain tumors.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Glioma is an aggressive brain tumor with limited treatment options.
- Kinesin superfamily proteins (KIFs) are motor proteins vital for cell functions implicated in cancer.
- Understanding KIFs' role in glioma is critical for developing new therapies.
Purpose of the Study:
- To review the role of KIFs in glioma pathogenesis.
- To explore KIFs as potential therapeutic targets for glioma.
- To examine the interplay of KIFs with non-coding RNAs and signaling pathways in glioma.
Main Methods:
- Literature review of Kinesin superfamily proteins (KIFs) in glioma.
- Analysis of KIFs' influence on glioma cell proliferation, invasion, migration, and metastasis.
- Examination of KIFs' regulation of cell cycle and signaling pathways (PI3K-Akt, Wnt/β-catenin, Hedgehog).
- Investigation of KIFs' interaction with non-coding RNAs (circRNAs, miRNAs).
- Review of current KIF-targeting therapies (immunotherapy, chemotherapy, small-molecule inhibitors).
Main Results:
- KIFs significantly contribute to glioma progression by influencing cell proliferation, invasion, migration, and metastasis.
- KIFs regulate critical cell cycle and signaling pathways involved in glioma.
- KIFs interact with non-coding RNAs, impacting glioma development.
- Various therapeutic strategies targeting KIFs show potential for improving glioma treatment outcomes.
Conclusions:
- Kinesin superfamily proteins (KIFs) play a multifaceted role in glioma pathogenesis.
- KIFs represent promising novel therapeutic targets for glioma treatment.
- Targeting KIFs, in combination with other strategies, may enhance outcomes for glioma patients.
Related Concept Videos
Destabilization of Microtubules
The Movement of Organelles and Vesicles
Microtubule Associated Motor Proteins
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Cancer Cell Migration through Invadopodia

